Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683161 · ClinicalTrials.gov registry record · Phase 2
Pre to Postoperative Smoking Cessation
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02683161: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT02683161 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02683161, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The study will evaluate the feasibility of integrating an intensive pre- post-surgical smoking cessation intervention into a hospital setting, and assess measures of postsurgical recovery as a function of smoking cessation status.
Primary Outcome
Smoking abstinence is defined the change in number of self-reported cigarettes smoked per week
Interventions
- DRUG Varenicline
- BEHAVIORAL Contingency Management
- BEHAVIORAL Behavioral Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-07 |
| Phase | Phase 2 |
Why NCT02683161 stopped before completion
NCT02683161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Varenicline is the first listed.
NCT02683161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02683161 about?
NCT02683161 is a clinical study titled "Pre to Postoperative Smoking Cessation". The study will evaluate the feasibility of integrating an intensive pre- post-surgical smoking cessation intervention into a hospital setting, and assess measures of postsurgical recovery as a function of smoking cessation status.
What is the current status of trial NCT02683161?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2015-10. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02683161?
The interventions under investigation include: Varenicline (DRUG), Contingency Management (BEHAVIORAL), Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02683161?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02683161's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia